CENTESSA PHARMACEUTICA

16.14

07-November-24 15:59:56

15 minutes delayed

Stocks

+0.15

+0.94%

Today's range

15.87 - 16.35

ISIN

N/A

Source

NASDAQ

Centessa Pharmaceuticals Announces Third Quarter 2021 Financial Results and Business Updates

15 Nov 2021 07:00:03 By Nasdaq GlobeNewswire
Centessa Pharmaceuticals to Present at Upcoming Conferences in 2021

10 Nov 2021 16:45:00 By Nasdaq GlobeNewswire
Centessa Pharmaceuticals Demonstrates Proof-of-Mechanism from First Three PiMZ Subjects Dosed in Part B of Phase 1 Study Evaluating ZF874

01 Nov 2021 07:30:00 By Nasdaq GlobeNewswire
Centessa Pharmaceuticals Subsidiary, Orexia Therapeutics, and Schrödinger Announce Collaboration to Discover Novel Orexin Receptor Agonists

18 Oct 2021 08:00:01 By Nasdaq GlobeNewswire
Centessa Pharmaceuticals Appoints David Grainger, PhD, a Leading Biotech Entrepreneur, as Chief Innovation Officer

05 Oct 2021 08:00:01 By Nasdaq GlobeNewswire
Centessa Pharmaceuticals Announces $300 Million Financing Agreement with Oberland Capital

04 Oct 2021 08:00:01 By Nasdaq GlobeNewswire
Centessa Pharmaceuticals Announces Positive Topline Data from Proof-of-Concept Study of SerpinPC in Severe Hemophilia A and B Patients Not on Prophylaxis

09 Sep 2021 07:30:00 By Nasdaq GlobeNewswire
Centessa Pharmaceuticals to Present at the Morgan Stanley Virtual 19th Annual Global Healthcare Conference

01 Sep 2021 16:15:00 By Nasdaq GlobeNewswire
Centessa Pharmaceuticals Announces Second Quarter 2021 Financial Results and Business Updates

16 Aug 2021 07:00:01 By Nasdaq GlobeNewswire
Centessa Pharmaceuticals to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference

07 Jun 2021 16:15:00 By Nasdaq GlobeNewswire

<<
<
1
2
3
4
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.